Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Medical consequences of obesity.

Bray GA.

J Clin Endocrinol Metab. 2004 Jun;89(6):2583-9. Review.

PMID:
15181027
2.

Childhood obesity, adipose tissue distribution, and the pediatric practitioner.

Slyper AH.

Pediatrics. 1998 Jul;102(1):e4. Review.

PMID:
9651456
3.

Sleep apnea is a manifestation of the metabolic syndrome.

Vgontzas AN, Bixler EO, Chrousos GP.

Sleep Med Rev. 2005 Jun;9(3):211-24. Review.

PMID:
15893251
4.

Adipose tissue dysfunction in obesity.

Blüher M.

Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8. Review.

PMID:
19358089
5.

From obesity to diabetes.

Keller U.

Int J Vitam Nutr Res. 2006 Jul;76(4):172-7. Review.

PMID:
17243079
6.

Overview of epidemiology and contribution of obesity to cardiovascular disease.

Bastien M, Poirier P, Lemieux I, Després JP.

Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):369-81. doi: 10.1016/j.pcad.2013.10.016. Epub 2013 Oct 24. Review.

PMID:
24438728
7.

Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.

Bozzetto L, Prinster A, Mancini M, Giacco R, De Natale C, Salvatore M, Riccardi G, Rivellese AA, Annuzzi G.

Eur J Clin Invest. 2011 Jan;41(1):39-44. doi: 10.1111/j.1365-2362.2010.02372.x. Epub 2010 Sep 6.

PMID:
20825466
8.

Body fat distribution, insulin resistance, and metabolic diseases.

Björntorp P.

Nutrition. 1997 Sep;13(9):795-803. Review.

PMID:
9290093
9.

Obesity and Liver Cancer.

Aleksandrova K, Stelmach-Mardas M, Schlesinger S.

Recent Results Cancer Res. 2016;208:177-198. Review.

PMID:
27909908
10.

Risks of obesity.

Bray GA.

Prim Care. 2003 Jun;30(2):281-99, v-vi. Review.

PMID:
14567148
11.

Adipose tissue dysfunction contributes to obesity related metabolic diseases.

Blüher M.

Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):163-77. doi: 10.1016/j.beem.2013.02.005. Epub 2013 Mar 6. Review.

PMID:
23731879
12.

The regulation of adipose tissue distribution in humans.

Björntorp P.

Int J Obes Relat Metab Disord. 1996 Apr;20(4):291-302. Review.

PMID:
8680455
13.

The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.

Chalmers L, Kaskel FJ, Bamgbola O.

Adv Chronic Kidney Dis. 2006 Oct;13(4):352-64. Review.

PMID:
17045221
14.

Changes in physiology with increasing fat mass.

Schuster DP.

Semin Pediatr Surg. 2009 Aug;18(3):126-35. doi: 10.1053/j.sempedsurg.2009.04.002.

PMID:
19573754
15.

Visceral fat as a determinant of fibrinolysis and hemostasis.

Mertens I, Van Gaal LF.

Semin Vasc Med. 2005 Feb;5(1):48-55. Review.

PMID:
15968580
17.

Once fat was fat and that was that: our changing perspectives on adipose tissue.

Ferris WF, Crowther NJ.

Cardiovasc J Afr. 2011 May-Jun;22(3):147-54. Review.

18.

The adipose tissue as a source of vasoactive factors.

Frühbeck G.

Curr Med Chem Cardiovasc Hematol Agents. 2004 Jul;2(3):197-208. Review.

PMID:
15320786
19.

Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.

Skurk T, Hauner H.

Int J Obes Relat Metab Disord. 2004 Nov;28(11):1357-64. Review.

PMID:
15356668
20.

Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.

Trayhurn P, Beattie JH.

Proc Nutr Soc. 2001 Aug;60(3):329-39. Review.

PMID:
11681807

Supplemental Content

Support Center